- Home
- / Jena Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jena Bioscience financials data including stock price, CreditSafe score, balance sheet, and acquistions and subsidiaries.
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|
| Cash | 1.8M | 2.4M | 2.3M |
| Accounts Receivable | 695.2K | 961.9K | 882.2K |
| Prepaid Expenses | 17.8K | 21.3K | 63.1K |
| Inventories | 55.4K | 401.8K | 753.8K |
| Current Assets | 2.6M | 3.7M | 3.9M |
| PP&E | 5.2M | 5.1M | 5.0M |
| Total Assets | 8.3M | 9.4M | 10.6M |
| Total Liabilities | 3.6M | 4.5M | 5.0M |
| Common Stock | 30.0K | 30.0K | 30.0K |
| Total Equity | 4.7M | 4.9M | 5.6M |
| Financial Leverage | 1.8 | 1.9 | 1.9 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |